| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1994;107:19-28
© 1994 Mosby, Inc.
GENERAL THORACIC SURGERY |
London, United Kingdom
From the Royal Brompton and National Heart and Lung Hospital, London, United Kingdom.
Address for reprints: Peter Goldstraw, FRCS, Royal Brompton and National Heart and Lung Hospital, Sydney Street, London SW3, United Kingdom
Abstract
Between 1979 and 1989, 876 patients with non-small-cell lung carcinoma were referred to our unit for surgical treatment. One hundred forty-six patients were judged not suitable for surgical treatment on clinical, radiologic, or bronchoscopic findings. Cervical mediastinoscopy or anterior mediastinotomy (or both) showed that 151 patients had mediastinal involvement by invasion or metastases into the ipsilateral (N2 disease) or contralateral (N3 disease) superior mediastinal lymph nodes and were therefore deemed inoperable. Except for one patient who had involvement of a single nodal station at mediastinoscopy, all other patients (n = 578) undergoing thoracotomy were thought, on the basis of computed tomographic scan or mediastinal exploration (or both) not to have N2 disease. Despite our efforts to avoid surgery on patients with N2 disease, at thoracotomy routine mediastinal node dissection disclosed that 149 patients had unsuspected N2 disease. Resection was possible in 130 (87.3%) by pneumonectomy (n = 72), bilobectomy (n = 7), lobectomy (n = 49), or lesser resection (n = 2). In three patients the resection was incomplete (2.3%), but in 127 a complete resection was performed (85%). Histologic examination in these 149 patients showed that 72 tumors were squamous cell carcinoma, 54 adenocarcinoma, 14 large-cell carcinoma, and 9 of mixed type. Eight patients died in the hospital after thoracotomy. Adjuvant therapy was not used after complete resection. Complete follow-up was obtained in 134 patients and the mean follow-up period was 27.25 months (1 to 116 months). The actuarial 5-year survival for those having complete resection was 20.1%. There was a statistically significant difference favoring long-term survival in those patients with squamous cell carcinoma (p < 0.01) and those in whom only one nodal station was involved (p < 0.05). Neither the extent of resection nor the involvement of any specific nodal station influenced long-term survival. Despite rigorous preoperative investigations, routine mediastinal node dissection demonstrated mediastinal node metastasis for the first time at thoracotomy in 26% of our patients. We believe resection is justified in these patients, who have already necessarily incurred the morbidity and mortality of thoracotomy, so long as complete resection is possible. (J THORAC CARDIOVASC SURG 1994;107:19-28)
This article has been cited by other articles:
|
|
 |
|
  Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent n2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy. Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riquet, P. Bagan, F. Le Pimpec Barthes, E. Banu, F. Scotte, C. Foucault, A. Dujon, and C. Danel Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Ann. Thorac. Surg., December 1, 2007; 84(6): 1818 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Robinson, J. C. Ruckdeschel, H. Wagner Jr, and C. W. Stevens Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 243S - 265S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mizuguchi, N. Nishiyama, T. Iwata, T. Nishida, N. Izumi, T. Tsukioka, K. Inoue, M. Kameyama, and S. Suehiro Clinical Value of Serum Cytokeratin 19 Fragment and Sialyl-Lewis X in Non-Small Cell Lung Cancer Ann. Thorac. Surg., January 1, 2007; 83(1): 216 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mizuguchi, K. Inoue, T. Iwata, T. Nishida, N. Izumi, T. Tsukioka, N. Nishiyama, T. Uenishi, and S. Suehiro High Serum Concentrations of Sialyl Lewisx Predict Multilevel N2 Disease in Non-Small-Cell Lung Cancer Ann. Surg. Oncol., July 1, 2006; 13(7): 1010 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Casali, A. Stefani, P. Natali, G. Rossi, and U. Morandi Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 33 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Misthos, E. Sepsas, K. Athanassiadi, S. Kakaris, and I. Skottis Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 502 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inoue, N. Sawabata, S.-i. Takeda, M. Ohta, Y. Ohno, and H. Maeda Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.K. Connolly, P.E.Y. Van Schil, R. Milroy, O. Braendli, and R.J. Prescott The approach to the surgical management of cancer in four European countries Eur. Respir. J., November 1, 2003; 22(5): 838 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tomita, Y. Matsuzaki, M. Edagawa, T. Shimizu, M. Hara, and T. Onitsuka Lack of prognostic significance of tumor angiogenesis in resected pN2 non-small cell lung cancer Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 201 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Israel, M. Mor, D. Gaitini, Z. Keidar, L. Guralnik, A. Engel, A. Frenkel, R. Bar-Shalom, and A. Kuten Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/CT System Using 18F-FDG J. Nucl. Med., September 1, 2002; 43(9): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deslauriers Current surgical treatment of nonsmall cell lung cancer 2001 Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Esnaola, S. N. Lazarides, S. J. Mentzer, and K. M. Kuntz Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer J. Clin. Oncol., January 1, 2002; 20(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mouroux, N. Venissac, and M. Alifano Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer Ann. Thorac. Surg., November 1, 2001; 72(5): 1698 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ichinose, H. Kato, T. Koike, R. Tsuchiya, T. Fujisawa, N. Shimizu, Y. Watanabe, T. Mitsudomi, M. Yoshimura, and M. Tsuboi Completely resected stage IIIA non-small cell lung cancer: The significance of primary tumor location and N2 station J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takamochi, K. Nagai, K. Suzuki, J. Yoshida, Y. Ohde, and Y. Nishiwaki Clinical Predictors of N2 Disease in Non-small Cell Lung Cancer Chest, June 1, 2000; 117(6): 1577 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Lee, M. Machtay, L. R. Kaiser, J. S. Friedberg, S. M. Hahn, M. G. McKenna, and W. G. McKenna Non-Small Cell Lung Cancer: Prognostic Factors in Patients Treated with Surgery and Postoperative Radiation Therapy Radiology, December 1, 1999; 213(3): 845 - 852. [Abstract] [Full Text]
|
|
|
|
|
|
T. Naruke, R. Tsuchiya, H. Kondo, H. Nakayama, and H. Asamura Lymph node sampling in lung cancer: how should it be done? Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S17 - S24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL? J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki THE PROGNOSIS OF SURGICALLY RESECTED N2 NON-SMALL CELL LUNGCANCER: THE IMPORTANCE OF CLINICAL N STATUS J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 145 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vansteenkiste, P. De Leyn, G. Deneffe, J. Menten, T. Lerut, and M. Demedts Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Lewis, R. J. Caccavale, G. E. Sisler, J.-P. Bocage, and J. W. Mackenzie VATS Simultaneously Stapled Lobectomy Ann. Thorac. Surg., December 1, 1997; 64 (6): 1869 - 1871. [Full Text]
|
|
|
|
|
|
J. F. Vansteenkiste, P. R. De Leyn, G. J. Deneffe, G. Stalpaert, K. L. Nackaerts, T. E. Lerut, and M. G. Demedts Survival and Prognostic Factors in Resected N2 Non-Small Cell Lung Cancer: A Study of 140 Cases Ann. Thorac. Surg., May 1, 1997; 63(5): 1441 - 1450. [Abstract] [Full Text]
|
|
|
|
|
|
H. Akamatsu, M. Terashima, T. Koike, T. Takizawa, and Y. Kurita Staging of Primary Lung Cancer by Computed Tomography-Guided Percutaneous Needle Cytology of Mediastinal Lymph Nodes Ann. Thorac. Surg., August 1, 1996; 62(2): 352 - 355. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
